MGP Biotechnologies, LLC

Location:CA, US
Speaker:Dr. Roger Acey
Title:President and Founder
Primary Industry:Pharma & Biotech
Executive Summary:MGP is an early stage biotechnology company organized as an LLC. Our mission is to develop innovative products, methodologies, and intellectual property to unique and commercially valuable opportunities relevant to human health. Our patented technology is based on a novel metal binding protein (MT) that has a wide range of applications. These include removal of mercury based preservatives from vaccines, chelation therapy, agents for the treatment of autoimmune diseases, detection and treatment of tumors, water remediation (potable and industrial), environmental cleanup (civilian and military), and recovery of precious metals. Our initial target market is to develop a point-of-use syringe filter for removal of the mercury based preservative thimerosal from flu vaccine.
Venture is:A-Round

HIGHLIGHTS

Merck
Corporate Symposium

Harvard OTD
Partner Sponsor

2008 Corporate Presentations

Air Products
Boeing
BP
Cabot
Honda
Kodak
Medtronic
Merck
  • BASF
  • Genzyme
  • Lockheed Martin
  • Sanyo

Event Sponsors

Univalor
AzTE
Jackson Walker

Collocated Events

June 1-5, 2008
Nanotech 2008
Clean Technology 2008
BioNano 2008

Press Sponsor

Business Wire

Commercialization Partner

BusinessWeek

Media Sponsors

(joint with Nanotech 2008) Nature
Science
Red Herring

Supporting Organizations

Boston University
Midwest Research University Network
piribo

 

“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
 
Matthew Laudon, Co-Founder and Director of TechConnect